These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27786237)

  • 1. Pharmacotherapy: Current role of β-blockers after MI in patients without HF.
    Mukherjee D; Eagle KA
    Nat Rev Cardiol; 2016 Dec; 13(12):699-700. PubMed ID: 27786237
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: Beta-blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction.
    Ko DT; Hebert PR; Krumholz HM
    ACP J Club; 2003; 138(1):30; author reply 30. PubMed ID: 12511138
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery disease. Are β-blockers truly helpful in patients with CAD?
    Danchin N; Laurent S
    Nat Rev Cardiol; 2013 Jan; 10(1):11-2. PubMed ID: 23149827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Lapane KL; Hume AL
    JAMA; 1997 May; 277(18):1435; author reply 1436-7. PubMed ID: 9145710
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
    J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Jay SJ
    JAMA; 1997 May; 277(18):1434-5; author reply 1436-7. PubMed ID: 9145709
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardioprotection: Where to from here?
    Kloner RA; Hale SL; Dai W; Shi J
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):53-61. PubMed ID: 27714476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention.
    Boden WE; Maron DJ
    J Am Coll Cardiol; 2008 Apr; 51(13):1255-7. PubMed ID: 18371554
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
    Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Gambassi G; Bernabei R; Carbonin P
    JAMA; 1997 May; 277(18):1433-4; author reply 1436-7. PubMed ID: 9145707
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy for prognostic improvement after acute myocardial infarct].
    Willenbrock R; Monti J; Dietz R
    Herz; 1999 Aug; 24(5):389-97. PubMed ID: 10505289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Holt RJ
    JAMA; 1997 May; 277(18):1434; author reply 1436-7. PubMed ID: 9145708
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Rumboldt Z; Bozic I; Rakic D
    JAMA; 1997 May; 277(18):1435-6; author reply 1436-7. PubMed ID: 9145711
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Levinson D
    JAMA; 1997 May; 277(18):1436; author reply 1436-7. PubMed ID: 9145713
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Hein HA
    JAMA; 1997 May; 277(18):1436; author reply 1436-7. PubMed ID: 9145712
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
    Avezum A; Pais P; Flather MD; Anand S; Yusuf S
    Indian Heart J; 1995; 47(2):95-105. PubMed ID: 7590849
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between combining evidence-based medications on mortality following myocardial infarction in patients with and without renal impairment.
    Tay EL; Chan M; Tan V; Sim LL; Tan HC; Lim YT; Ho KT; Chia BL; Wong PS; Yeo TC
    Acta Cardiol; 2010 Apr; 65(2):211-6. PubMed ID: 20458829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
    Tuppin P; Neumann A; Danchin N; de Peretti C; Weill A; Ricordeau P; Allemand H
    Arch Cardiovasc Dis; 2010; 103(6-7):363-75. PubMed ID: 20800800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The current role of beta-blockers in coronary insufficiency].
    Witchitz S
    Rev Prat; 1988 Mar; 38(9):535-41. PubMed ID: 2895955
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-adrenoceptor blockers. An update on their role in acute myocardial infarction.
    Norris RM
    Drugs; 1985 Feb; 29(2):97-104. PubMed ID: 2858386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.